Video Experimental Relacionado
Updated: May 15, 2026
09:04
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 8, 2010
Los controles de reclutamiento del adaptador mediado por fosfoinositida controlan la señalización de receptores de
Jonathan C Kagan1, Ruslan Medzhitov
1Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Cell
|June 6, 2006
Resumen
Los receptores tipo peaje (TLR) inician respuestas inmunes a través de las proteínas adaptadoras. Este estudio revela cómo TIRAP recluta MyD88 a TLR4, aclarando un paso clave en las vías de señalización de la inmunidad innata.
Área de la Ciencia:
- Inmunología Inmunología.
- Biología celular Biología celular.
- Biología Molecular Biología Molecular
Sus antecedentes:
- Los receptores tipo peaje (TLR) son cruciales para la inmunidad innata, ya que detectan infecciones microbianas.
- Las proteínas adaptadoras como MyD88 y TIRAP son esenciales para la señalización TLR, pero sus funciones precisas siguen sin estar claras.
Objetivo del estudio:
- Para aclarar las funciones distintas de TIRAP y MyD88 en la señalización TLR.
- Describir el mecanismo de reclutamiento de TIRAP y MyD88 para el receptor de tipo Toll 4 (TLR4).
Principales métodos:
- Investigó el mecanismo de reclutamiento de TIRAP y MyD88 a TLR4.
- Se identificó un dominio de unión al fosfatidilinositol 4,5-bisfosfato (PIP2) dentro del TIRAP.
Principales resultados:
- TIRAP posee un dominio de unión PIP2, mediando su reclutamiento a la membrana plasmática.
- TIRAP facilita la entrega de MyD88 al TLR4 activado, iniciando la transducción de la señal aguas abajo.
- Se demostraron roles distintos para TIRAP y MyD88 en la vía de señalización TLR4.
Conclusiones:
- El reclutamiento de adaptadores mediado por fosfoinositida es un mecanismo clave para iniciar vías específicas de transducción de señales TLR.
- Este estudio aclara los roles secuenciales de TIRAP y MyD88 en la activación de TLR4 y el inicio de la respuesta inmune.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:26Signal Transduction: Overview
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: